Acute toxicity studies of Myrsine africana aqueous seed extract in male Wistar rats on some hematological and biochemical parameters

Springer Science and Business Media LLC - Tập 1 - Trang 1-4 - 2015
Zelipha N. Kabubii1, James Mbaria1, Mbaabu Mathiu2
1Department of Public Health, Pharmacology and Toxicology, University of Nairobi, Nairobi, Kenya
2Department of Veterinary Anatomy and Physiology, University of Nairobi, Nairobi, Kenya

Tóm tắt

Natural medicinal products have gained recognition worldwide in the treatment and control of diseases. One of the major concerns as they are used is the lack of adequate pharmacological and toxicological data to support their use. Myrsine africana is traditionally used as human and veterinary anthelmintic. Two groups of male Wistar rats were orally given as a single dose 1000 and 5000 mg/kg body weight of the M. africana extract respectively. Hematological and biochemical assays of each animal blood were done after 48 h and at day 14. No animal died in the entire study period. The median lethal dose (LD50) of the seed extract was estimated to be above 5000 mg/kg body weight in Wistar rats. Red blood cells, packed cell volume and creatinine in rats fed with 5000 mg/kg body weight were found to be significantly elevated from the control at 48 h. At day 14, thrombocytes and aspartate aminotransferase were significantly elevated in the high dose group while urea level had decreased significantly in the treatment groups. M. africana extract was found to have a high safe margin validating its wide use. However, caution should be exercised when using this extract as was indicated by the altered parameters. It is therefore recommended that lower doses than 1000 mg/kg body weight should be used for treatment.

Tài liệu tham khảo

World Health Organization (WHO). Herbal medicine research and global health; an ethical analysis. Bulletin of the. 2008;86(8):577–656. Stanley B. "Recognition and respect for African Traditional Medicine". National Coordinating Agency for pupation and Development (NCAPD), “Draft Policy on Traditional Medicine and Medicinal Plants”, Nairobi 2004. Alam MB, Hossain MS, Chowdhury NS, Mazumder MEH, Haque ME. In -vitro and in- vivo antioxidant and toxicity evaluation of different fractions of corniculata linn. J Pharmacol Toxicol. 2011;6:337–48. Park M, Choi H, Kim J, Lee H, Ku S. 28 days repeated oral dose toxicity test of aqueous extracts of Mahwangyounpae-tang, a polyherbal formula. Food Chem Toxicol. 2010;48:2477–82. De Smet PM. Health risk of herbal remedies. Drug Saf. 1995;13(2):81–93. Cheng ZF, Zhen C. The Cheng Zhi-Fan Collectanea of Medical History. Beijing China: Peking University Medical Press; 2004. Organization for Economic Co-operation and Development (OECD). Guidance document on acute oral toxicity. Environmental health and safety monograph Series on testing and assessment .2000: No 24. Robinson S, Ockert D, Stei P, Dreher D. Challenging the regulatory requirement for conventional acute toxicity studies in pharmaceutical drug development. Toxicol. 2007;231(2–3):96. Gathuma JM, Mbaria JM, Wanyama J, Kaburia HF, Mpolce LJN. Samburu and Turkana healers. Efficacy of Myrsine africana, Albizia anthelmintica and Hilderbrantia sepalosa herbal remedies against mixed natural sheep helminthosis in Samburu district, Kenya. J Ethnopharmacol. 2004;91:7–12. Mbaabu M, Matu EN. Medicinal plants utilization in the treatment of human and livestock diseases in Meru. Pharm J. 2013;1(2):18–24. Zhong HB. State administration of traditional Chinese medicine of the people’s republic of China, third edition. China: Shanghai Science and Technology Press; 1985. p. 245–95. Kokwaro JO. Medicinal plants of East Africa. 2nd ed. Nairobi: Kenya literature Bureau; 1993. p. 401–50. Zabta KS, Ashiq AK, Toshiyuki N. Medicinal plants and other useful plants of District Swat. Peshawar, Pakistan: Pakistan. Al Aziz Press; 2003. p. 79–210. Beentje H. Kenya Trees, Shrubs, and Lianas; National Museums of Kenya. 1994. Schorderet M. Pharmacologie des concepts fondamentaux aux applications theurapeutiques. Editions Frison-Roche Paris: Editions Slatkine Genève; 1992. p. 33–4. Imaga NOA, Gbenle GO, Okochi VI, Akanbi SO, Edeoghon SO, Oigbochie V, et al. Antisickling property of Carica papaya leaf extract. Afric J Biochem Res. 2009;3(4):102–6. Banerjee SK, Maulik SK. Effect of garlic on cardiovascular disorders: A review. J Nutr. 2002;4(1):1–14. Zhong GS, Wan F. An outline on the early pharmaceutical development before Galen. Chin J Med Hist. 1999;29:178–82. Nanyingi MO, Mbaria JM, Lanyasunya AL, Wagate CG, Koros KB, Kaburia HF, et al. Ethnopharmacological survey of Samburu district of Kenya. J Ethnobiol Ethnomed. 2008;4:14–9. Ahmad N, Fazal H, Ayaz M, Abbasi BH, Mohamma I, Fazal L. Dengue fever treatment with Carica papaya leaves extracts. Asian Pac J Trop Biomed. 2011;1:330–3. Rhodes C, Thomas M, Athis J. Principles of testing for acute toxic effects. In: Ballantyne B, Marrs T, Turner P, editors. General and Applied Toxicology, vol. (1)1. New York, USA: Stockton; 1993. p. 49–87. Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, et al. Concordance of toxicity of pharmaceuticals in humans and in animals. Reg Toxicol Pharmacol. 2000;32:56. Shah R, Parmar S, Bhatt P, Chandra S. Evaluation of hepatoprotective activity of ethyl acetate fraction of “Tephrosiapurpurea”. Pharmacol Online. 2011;3:188–94. Cavanaugh BM. Nurse’s: Manual of Laboratory and Diagnostics Tests. 4th ed. Philadelphia: FA. Davis Company; 2003. p. 688–90. Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S. The current state of serum biomarkers of hepatotoxicity. Toxicol. 2008;245:194–205. Eaton DC, Pooler JP. Vander’s Physiology. 7th ed. USA: McGraw-Hill Lange; 2009. p. 230–367. Burti CA, Ashwood ER, Bruns DE, Saunders WB. Tietz. Textbook of Clinical Chemistry, vol. 24. 4th ed. Philadelphia: Company; 2006. p. 801–3.